Christine G. Savage

Practice Group Leader - Healthcare

Christine Savage is Chair of Choate’s Healthcare group. In her practice she regularly collaborates with a diverse range of healthcare services and life sciences companies to help them satisfy compliance obligations, protect reputations, deliver value and ultimately facilitate their ability to focus on their patients or customers.

Her work includes helping emerging companies develop and implement key compliance initiatives and helping more established companies assess the legal risks associated with new business plans, conduct internal investigations, and manage government inquiries. She also spends a significant part of her practice advising leading universities and academic medical centers on matters involving the management of federal grant funds and allegations of scientific misconduct.

Practice Focus

Healthcare/Life Sciences Compliance – Represents direct health care service providers (e.g., hospitals, laboratories, diagnostic testing companies) and pharmaceutical and device manufacturers with complex compliance and regulatory issues including those implicating the Anti-Kickback Statute, False Claims Act, HIPAA/HITECH (including but not limited to suspected data breaches), and Open Payments. Assists clients in developing new business models, negotiating agreements, and building compliance guardrails for sales and marketing personnel.

Government Enforcement – Conduct internal investigations for health care/life sciences companies in response to whistleblower or other concerns, prepares self-disclosures when necessary and negotiates resolutions with relevant agencies, and represents institutions in health care fraud investigations. Negotiates Corporate Integrity Agreements and subsequently assists companies implement CIA-required compliance initiatives, prepare reportable event disclosures, resolve IRO disputes, and prepare required annual reports.

Institutional Research Compliance – Leads internal reviews for universities and academic medical centers where allegations of scientific misconduct or federal grants mismanagement have been raised and helps resolve material findings with appropriate government agencies. Advises IRBs, research institutions, and research sponsors on human subjects protection, privacy and related matters.  

Representative Engagements

  • Assisted major pharmaceutical company in identifying and resolving material legal impediments (in several states) to its ability to market an FDA approved product for its intended use.
  • Created a compliance program timeline for a pre-commercial pharmaceutical company and helped develop an appropriate Code of Conduct, HCP engagement policies and Investigator-Initiated Trials processes
  • Represented a global pharmaceutical company in a multi-year, multi-faceted government investigation regarding its voluntary withdrawal of a product.
  • Assisted a major research university investigate potential mismanagement of NIH grant funds
  • Counseled an academic medical center regarding potential False Claims Act implications of alleged scientific misconduct
  • Assisted a hospital in assessing and refunding overpayments associated with a series of identified physician billing and coding errors 

Publications and Presentations

Professional and Community Involvement

  • Vice-Chair, UMass Amherst Foundation Board of Trustees
  • Chair Emeritus, UMass Amherst College of Social and Behavioral Sciences Dean’s Advisory Board
  • Founding Member, UMass Club

Prior Civic Engagement: 

  • Member, BBA Health Law Steering Committee
  • Trustee, Massachusetts Chapter of the Arthritis Foundation
  • Member, Partners Institutional Review Board

Education & Credentials

Harvard Law School
JD, 1995, cum laude
University of Massachusetts Amherst
BA, 1992, cum laude, Harry S. Truman Scholar